pn 202-791 has been researched along with bay-k-8644 in 13 studies
| Studies (pn 202-791) | Trials (pn 202-791) | Recent Studies (post-2010) (pn 202-791) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
|---|---|---|---|---|---|
| 44 | 0 | 1 | 2,555 | 0 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henderson, G; Kennedy, C | 1 |
| Hammond, C; Henderson, G; Mason, WT; Morton, AJ | 1 |
| Bolger, GT; Campbell, N; Crowley, M; McKay, DW; O'Neill, SK; Triggle, CR | 1 |
| Luchowski, EM; Rutledge, A; Su, CM; Triggle, DJ; Wei, XY | 1 |
| Brown, AM; Brush, K; Hamilton, SL; Schwartz, A; Yatani, A | 1 |
| Baik, YH; Koch, WJ; Schwartz, A; Williams, JS | 1 |
| Boarder, MR; Owen, PJ; Plevin, R | 1 |
| Dakshinamurti, K; Lal, KJ | 1 |
| Bolger, GT; O'Neill, SK; Triggle, CR | 1 |
| Ehrenstein, G; Fitzpatrick, LA; Pocotte, SL | 1 |
| Glossmann, H; Hering, S; Strübing, C | 1 |
| Bieger, D; Martin-Caraballo, M; Triggle, CR | 1 |
| Kan, E; Kelly, JE; Lokuta, AJ; Nishio, M; Sagawa, K; Sagawa, T; Tsai, J; Wasserstrom, JA | 1 |
13 other study(ies) available for pn 202-791 and bay-k-8644
| Article | Year |
|---|---|
Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium Channel Blockers; Calcium Channels; Cell Line; Drug Tolerance; Humans; Kinetics; Membrane Potentials; Models, Biological; Mollusk Venoms; Morphine; Naloxone; Nicotinic Acids; omega-Conotoxin GVIA; Oxadiazoles; Peptides, Cyclic; Time Factors | 1992 |
Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: calcium imaging and single channel recording.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Cadmium; Cadmium Chloride; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Differentiation; Cell Line; Cell Membrane; Chlorides; Evoked Potentials; Fura-2; Humans; Kinetics; Microscopy, Fluorescence; Neuroblastoma; Nicotinic Acids; Nifedipine; omega-Conotoxins; Oxadiazoles; Peptides, Cyclic; Potassium; Tretinoin | 1992 |
Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium Channel Agonists; Catecholamines; Chromatography, High Pressure Liquid; Dihydropyridines; Guinea Pigs; Injections, Intraperitoneal; Male; Mice; Motor Activity; Muscle Contraction; Muscle, Smooth; Nicotinic Acids; Nifedipine; Oxadiazoles; Pyridines; Stereoisomerism; Structure-Activity Relationship | 1990 |
Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Calcium; Drug Synergism; Guinea Pigs; Ion Channels; Muscle Contraction; Muscle, Smooth, Vascular; Nicotinic Acids; Nitrendipine; Oxadiazoles; Potassium Chloride; Rats; Stereoisomerism | 1986 |
A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Guinea Pigs; Heart; Ion Channels; Isradipine; Kinetics; Membrane Potentials; Membranes; Myocardium; Nicotinic Acids; Nimodipine; Nitrendipine; Oxadiazoles; Pyridines; Stereoisomerism; Structure-Activity Relationship | 1987 |
A possible role for the endothelium in porcine coronary smooth muscle responses to dihydropyridine calcium channel modulators.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Endothelium; Histamine; Isomerism; Isosorbide Dinitrate; Muscle, Smooth, Vascular; Nicotinic Acids; Oxadiazoles; Swine; Vasoconstriction; Vasodilation | 1987 |
Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bradykinin; Calcium; Cattle; Cells, Cultured; Chromaffin Granules; Chromaffin System; Dose-Response Relationship, Drug; In Vitro Techniques; Inositol Phosphates; Nicotinic Acids; Nitrendipine; Norepinephrine; Oxadiazoles; Potassium | 1989 |
Calcium channels in vitamin B6 deficiency-induced hypertension.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Diltiazem; Hypertension; Male; Nicotinic Acids; Nifedipine; Oxadiazoles; Rats; Rats, Sprague-Dawley; Verapamil; Vitamin B 6 Deficiency | 1993 |
Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding, Competitive; Brain; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; In Vitro Techniques; Male; Membranes; Mice; Muscle Proteins; Nicotinic Acids; Nitrendipine; Oxadiazoles; Stereoisomerism; Thermodynamics | 1994 |
Role of calcium channels in parathyroid hormone secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cattle; Cyclic AMP; Electrophoresis, Polyacrylamide Gel; Ionomycin; Isotope Labeling; Nicotinic Acids; Nifedipine; Oxadiazoles; Parathyroid Glands; Parathyroid Hormone; Pertussis Toxin; Phosphorylation; Potassium; Radioimmunoassay; Stereoisomerism; Verapamil; Virulence Factors, Bordetella | 1995 |
Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Barium; Calcium Channel Blockers; Calcium Channels; Cell Line; Diffusion; Electrophysiology; Ion Channels; Mice; Muscle, Smooth; Muscles; Nicotinic Acids; Oxadiazoles; Potassium Channels; Spectrometry, Fluorescence | 1993 |
Photosensitization of oesophageal smooth muscle by 3-NO2-1, 4-dihydropyridines: evidence for two cyclic GMP-dependent effector pathways.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 3',5'-Cyclic-GMP Phosphodiesterases; Aminoquinolines; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium-Transporting ATPases; Chelating Agents; Egtazic Acid; Esophagus; Guanylate Cyclase; In Vitro Techniques; Indoles; Marine Toxins; Muscle, Smooth; Nicotinic Acids; Nitric Oxide; Oxadiazoles; Oxazoles; Phosphoprotein Phosphatases; Photosensitizing Agents; Purinones; Rats; Rats, Sprague-Dawley; Ryanodine | 1995 |
Activation of purified cardiac ryanodine receptors by dihydropyridine agonists.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Dogs; Membrane Potentials; Myocardium; Nicotinic Acids; Nifedipine; Oxadiazoles; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Stereoisomerism | 2001 |